A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

364

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Infliximab

Sponsor

Centocor, Inc.